Medical Key Opinion Leaders in Preeclampsia Join Pluristem's Steering Committee
Pluristem Therapeutics, Inc., a leading developer of placenta-based cell therapies, today announced it has formed a Preeclampsia Steering Committee to advance its PLacental eXpanded (PLX) cell therapies for the treatment of preeclampsia.
View full press release